All News

From FDA regulatory updates for products related to women's health, to a preview of upcoming annual meetings and conferences, we keep you updated on what's to come in Q2 of 2026.

Adnan I. Qureshi, MD, calls for a multidisciplinary action plan that integrates neurologists into obstetric teams to manage increased recurring stroke risk in pregnancy.

The FDA informed manufacturers of its intent to issue draft guidance by August 2026 to regulate unapproved animal-derived thyroid medications used by 1.5 million Americans.

Researchers reported in JAMA Health Forum that while expanded prenatal syphilis mandates improve near-term detection, they require additional public health support to maintain long-term efficacy.

Clinicians evaluating women with new or worsening urinary incontinence should consider thyroid dysfunction—especially hypothyroidism—as a potential contributing factor, with overflow symptoms and systemic hypothyroid signs prompting laboratory evaluation and a comprehensive management approach.

Alla Vash-Margita, MD, FACOG, details how identifying differentially expressed microRNAs in 13- to 26-year-olds could provide a pathway for early detection of endometriosis.

Willow Innovations launched 7 new breastfeeding and maternal care accessories to support postpartum care from feeding to storage of breast milk.

Livi is a single-use, soft polyurethane foam device cleared by the FDA to absorb semen and vaginal discharge within approximately 60 seconds.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A 4857-patient international RCT found that a single postpartum infusion of IV ferric carboxymaltose was superior to twice-daily oral iron in achieving a non-anemic hemoglobin level at 6 weeks, with sustained hemoglobin benefit through 6 months across all regions studied.

Sangini Sheth, MD, emphasizes that shared decision-making is vital when presenting patients with the choice between clinician-collected and self-collected hrHPV screening options.

Flo Health chief medical officer Anna Klepchukova and study investigator Erica Stockwell highlight the benefits of digital symptom checkers for endometriosis.

Among a survey of over 800 providers, menopause care was the top area for expected greatest improvement over the next 5 years.

Sangini Sheth, MD, MPH, highlights that the updated HRSA guidelines empower patients by offering FDA-approved self-collection options for primary HPV testing.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

A case report describes the first known use of low-intensity extracorporeal shock wave therapy for episiotomy scar pain, with a patient reporting meaningful improvement after more than 20 years of chronic pelvic floor dysfunction.

A retrospective study of more than 3200 cesarean deliveries found that patients with three or more prior cesareans have a 15% likelihood of a uterine window, supporting consideration of early-term delivery in this group.

Lam-Rachlin reported that the software did not add time to the examinations and, in some instances, appeared to speed up the process by providing a rapid preliminary analysis.

A randomized clinical trial found that weekly extended-release buprenorphine achieved significantly higher illicit opioid abstinence during pregnancy compared to daily sublingual doses.

A national EHR database study found that GLP-1 RA prescribing among perinatal patients increased more than thirtyfold between 2019 and 2024, with an estimated 20,000 pregnant individuals exposed in 2024 alone.

Data suggest that thermal biomodulation via radiofrequency improves vaginal lubrication and reduces pain during intercourse for postmenopausal women.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A large preconception cohort study found that nearly 41% of pregnancy planners tested more than 4 days before their expected period, a pattern associated with a fivefold higher risk of false-negative results and threefold higher detection of very early pregnancy losses.

Adnan I. Qureshi, MD, reports that women with a history of stroke have 2-fold higher odds of recurrence during pregnancy and the 6-week postpartum period.

Sara Perelmuter advocates for routine postpartum screening and provider education on lactation-safe therapies when dealing with GSL symptoms.

A longitudinal study found that third-trimester levels of sFlt-1 and hs-cTnI were an independently associated with higher long-term CVD risk.

Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.